Patents by Inventor George A. Ksander

George A. Ksander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating ophthalmic disorders using TGF -.beta.
    Patent number: 5767079
    Abstract: This invention is a method for the treatment of ophthalmic disorders. The method is suitable for treatment of a variety of disorders including macular holes, macular degeneration, and retinal detachment and tears, cataracts, and corneal and scleral injuries. The method entails application of an effective amount of Transforming Growth Factor-.beta. (TGF-.beta.) to the affected region.
    Type: Grant
    Filed: August 27, 1996
    Date of Patent: June 16, 1998
    Assignee: Celtrix Pharmaceuticals, Inc.
    Inventors: Bert M. Glaser, Bruce B. Pharriss, deceased, Ann F. Hanham, George A. Ksander
  • Wound-healing composition
    Patent number: 4760131
    Abstract: A soft tissue wound healing composition comprising an aqueous mixture of fibrillar collagen, heparin, and undegranulated platelets or platelet releasate. The composition is applied topically to the wound site in conjunction with means to keep it at the site and hydrated or in the form of an occlusive dressing.
    Type: Grant
    Filed: June 23, 1986
    Date of Patent: July 26, 1988
    Assignee: Collagen Corporation
    Inventors: John S. Sundsmo, George A. Ksander, John M. McPherson